Secret Genome Meeting

A closed-door gathering at Harvard last week hosted researchers talking about synthesizing entire genomes, including that of humans.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

DNAFLICKR, CAROLINE DAVIS2010Harvard Medical School’s George Church and his collaborators invited some 130 scientists, lawyers, entrepreneurs, and government officials to Boston last week (May 10) to discuss the feasibility and implementation of a project to synthesize entire large genomes in vitro. According to a statement Church provided to STAT News, such an endeavor could represent “the next chapter in our understanding of the blueprint of life.”

While the subject is an exciting one—on a smaller scale, Craig Venter’s group has synthesized the 1-million-base-pair genome of Mycoplasma mycoides—critics immediately took issue with the fact that this meeting was not open to the press. “This idea is an enormous step for the human species, and it shouldn’t be discussed only behind closed doors,” Northwestern University’s Laurie Zoloth told STAT News. She and Stanford University bioengineer Drew Endy published an article in Cosmos documenting their disapproval of the private nature of the meeting.

Church told STAT News that the original intention was to make the meeting open, but in anticipation of an imminent, high-profile publication on this project, he and his collaborators had to respect the journal’s embargo. However, Endy tweeted a photo of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies